id: absence_detoxification_protocols_to_variable_withdrawal_management
name: Absence of Official GHB Detoxification Protocols â†’ Variable Withdrawal Management
  Approaches
from_node:
  node_id: absence_detoxification_protocols
  node_name: Absence of Official GHB Detoxification Protocols
to_node:
  node_id: variable_withdrawal_management
  node_name: Variable Withdrawal Management Approaches
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: No official standardized detoxification protocols exist for GHB withdrawal
  syndrome'
- 'Step 2: Treatment decisions rely on clinical judgment based on benzodiazepine therapy'
- 'Step 3: When benzodiazepine monotherapy is ineffective, combination approaches
  with barbiturates or antipsychotics are used'
- 'Step 4: Lack of standardization creates variation in treatment quality and safety
  across healthcare settings'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'E. Marinelli et al. 2020. "Gamma-hydroxybutyrate Abuse: Pharmacology
    and Poisoning and Withdrawal Management." *Arhiv za Higijenu Rada i Toksikologiju*.
    https://doi.org/10.2478/aiht-2020-71-3314'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.699047'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: clinical_expertise_ghb
  direction: weakens
  strength: strong
  description: Greater clinical expertise with GHB withdrawal may reduce negative
    effects of protocol absence through experience-based decision-making
- name: benzodiazepine_efficacy
  direction: weakens
  strength: moderate
  description: When benzodiazepine monotherapy is effective, protocol absence has
    less impact on outcomes
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/absence_detoxification_protocols_to_variable_withdrawal_management.yaml
_category: healthcare_access
